<DOC>
	<DOC>NCT01395446</DOC>
	<brief_summary>The purpose of this study is to establish the accuracy with which the eNose can discriminate patients with invasive pulmonary aspergillosis from controls.</brief_summary>
	<brief_title>Application of an Electronic Nose in the Early Detection of ASpergillosis</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
	<criteria>Patients that 1. are 18 years of age or older 2. will undergo treatment for a hematological malignancy expected to result in grade 4 neutropenia (according to CTCAE 3.0, i.e. &lt;0.5 x 109 neutrophils/L) of prolonged duration (i.e., more than 7 days), e.g. hematopoietic stem cell transplantation or induction/consolidation treatment for acute myeloid leukaemia 3. have given written informed consent 1. a previously diagnosed invasive mycosis 2. the inability to perform the breathing manoeuvre needed for eNoseanalysis of exhaled air</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>